Siehler, J. ; Bilekova, S. ; Chapouton, P. ; Dema, A. ; Albanese, P.* ; Tamara, S.* ; Jain, C. ; Sterr, M. ; Enos, S.J. ; Chen, C. ; Malhotra, C. ; Villalba, A.* ; Schomann, L. ; Bhattacharya, S. ; Feng, J. ; Akgün, M. ; Ribaudo, F. ; Ansarullah ; Burtscher, I. ; Ahlbrecht, C. ; Plettenburg, O. ; Kurth, T.* ; Scharfmann, R.* ; Speier, S. ; Scheltema, R.A.* ; Lickert, H.
Inceptor binds to and directs insulin towards lysosomal degradation in β cells.
Nat. Metab. 6, 2374–2390 (2024)
Blunted first-phase insulin secretion and insulin deficiency are indicators of β cell dysfunction and diabetes manifestation. Therefore, insights into molecular mechanisms that regulate insulin homeostasis might provide entry sites to replenish insulin content and restore β cell function. Here, we identify the insulin inhibitory receptor (inceptor; encoded by the gene IIR/ELAPOR1) as an insulin-binding receptor that regulates insulin stores by lysosomal degradation. Using human induced pluripotent stem cell (SC)-derived islets, we show that IIR knockout (KO) results in enhanced SC β cell differentiation and survival. Strikingly, extended in vitro culture of IIR KO SC β cells leads to greatly increased insulin content and glucose-stimulated insulin secretion (GSIS). We find that inceptor localizes to clathrin-coated vesicles close to the plasma membrane and in the trans-Golgi network as well as in secretory granules, where it acts as a sorting receptor to direct proinsulin and insulin towards lysosomal degradation. Targeting inceptor using a monoclonal antibody increases proinsulin and insulin content and improves SC β cell GSIS. Altogether, our findings reveal the basic mechanisms of β cell insulin turnover and identify inceptor as an insulin degradation receptor.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Mannose 6-phosphate Receptors; Regulated Secretory Pathway; Carboxypeptidase E; Autophagy; Proinsulin; Granules; Identification
Keywords plus
Language
english
Publication Year
2024
Prepublished in Year
0
HGF-reported in Year
2024
ISSN (print) / ISBN
2522-5812
e-ISSN
2522-5812
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 6,
Issue: 12,
Pages: 2374–2390
Article Number: ,
Supplement: ,
Series
Publisher
Springer
Publishing Place
London
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30201 - Metabolic Health
90000 - German Center for Diabetes Research
30203 - Molecular Targets and Therapies
Research field(s)
Helmholtz Diabetes Center
Enabling and Novel Technologies
PSP Element(s)
G-502300-001
G-501900-231
G-502301-001
G-502600-005
G-506300-001
Grants
Marie Curie Actions (MSCA)
Helmholtz Future Topic 'Aging and Metabolic programming' (AMPro)
Helmholtz Society
Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease'
German Research Foundation
German Center for Diabetes Research (DZD)
European Research Council
NWO TA grant
European Union Horizon 2020 programme INFRAIA project Epic-XS
Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH)
European Union
Copyright
Erfassungsdatum
2024-12-03